|
2021 Journal Article Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analysesKang, Eun Young, Cheasley, Dane, LePage, Cecile, Wakefield, Matthew J., da Cunha Torres, Michelle, Rowley, Simone, Salazar, Carolina, Xing, Zhongyue, Allan, Prue, Bowtell, David D. L., Mes-Masson, Anne-Marie, Provencher, Diane M., Rahimi, Kurosh, Kelemen, Linda E., Fasching, Peter A., Doherty, Jennifer A., Goodman, Marc T., Goode, Ellen L., Deen, Suha, Pharoah, Paul D. P., Brenton, James D., Sieh, Weiva, Mateoiu, Constantina, Sundfeldt, Karin, Cook, Linda S., Le, Nhu D., Anglesio, Michael S., Gilks, C. Blake, Huntsman, David G. ... Campbell, Ian G. (2021). Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses. Modern Pathology, 34 (1), 194-206. doi: 10.1038/s41379-020-0618-9 |
|
2020 Conference Publication Haemoglobin, body mass index and age as risk-factors for paclitaxel- and oxaliplatin-induced peripheral neuropathyMizrahi, D., Park, S. B., Li, T., Timmins, H., Trinh, T., Au, K., Battaglini, E., Wyld, D., Henderson, R., Grimison, P., Ke, H., Marker, J., Wall, B. and Goldstein, D. (2020). Haemoglobin, body mass index and age as risk-factors for paclitaxel- and oxaliplatin-induced peripheral neuropathy. ESMO Asia Virtual Congress, Electr Network, Nov 20-22, 2020. AMSTERDAM: ELSEVIER. doi: 10.1016/j.annonc.2020.10.328 |
|
2020 Journal Article PET imaging quantifying Ga-PSMA-11 uptake in metastatic colorectal cancerCuda, Tahleesa J., Riddell, Andrew D., Liu, Cheng, Whitehall, Vicki L., Borowsky, Jennifer, Wyld, David K., Burge, Matthew E., Ahern, Elizabeth, Griffin, Alison, Lyons, Nicholas J. R., Rose, Stephen E., Clark, David A., Stevenson, Andrew R. L., Hooper, John D., Puttick, Simon and Thomas, Paul A. (2020). PET imaging quantifying Ga-PSMA-11 uptake in metastatic colorectal cancer. The Journal of Nuclear Medicine, 61 (11), 1576-1579. doi: 10.2967/jnumed.119.233312 |
|
2020 Journal Article Statistical Process Control assessed implementation fidelity of Patient Reported Outcome Measures (PROMs) in routine careRoberts, Natasha A., Alexander, Kimberly, Wyld, David and Janda, Monika (2020). Statistical Process Control assessed implementation fidelity of Patient Reported Outcome Measures (PROMs) in routine care. Journal of Clinical Epidemiology, 127, 76-86. doi: 10.1016/j.jclinepi.2020.06.022 |
|
2020 Journal Article The utility of the implementation science framework “Integrated Promoting Action on Research Implementation in Health Services” (i-PARIHS) and the facilitator role for introducing patient-reported outcome measures (PROMs) in a medical oncology outpatient departmentRoberts, Natasha A., Janda, Monika, Stover, Angela M., Alexander, Kimberly E., Wyld, David and Mudge, Alison (2020). The utility of the implementation science framework “Integrated Promoting Action on Research Implementation in Health Services” (i-PARIHS) and the facilitator role for introducing patient-reported outcome measures (PROMs) in a medical oncology outpatient department. Quality of Life Research, 30 (11), 3063-3071. doi: 10.1007/s11136-020-02669-1 |
|
2020 Journal Article Determining the CA19-9 concentration that best predicts the presence of CT-occult unresectable features in patients with pancreatic cancer: a population-based analysisMcGahan, William, Waterhouse, Mary A., O'Connell, Dianne L., Merrett, Neil D., Goldstein, David, Wyld, David, Burmeister, Elizabeth A., Jordan, Susan J. and Neale, Rachel E. (2020). Determining the CA19-9 concentration that best predicts the presence of CT-occult unresectable features in patients with pancreatic cancer: a population-based analysis. Pancreatology, 20 (7), 1458-1464. doi: 10.1016/j.pan.2020.07.405 |
|
2020 Journal Article Trends in epidemiology, treatment and molecular testing of metastatic colorectal cancer in a real‐world multi‐institution cohort studyKuchel, Anna, Ahern, Elizabeth, Collins, Stephanie, Whitehall, Vicki, Okano, Satomi, Pelecanos, Anita, Wyld, David, Eastgate, Melissa and Burge, Matthew (2020). Trends in epidemiology, treatment and molecular testing of metastatic colorectal cancer in a real‐world multi‐institution cohort study. Asia-Pacific Journal of Clinical Oncology, 17 (1) ajco.13420, 84-93. doi: 10.1111/ajco.13420 |
|
2020 Journal Article Prognostic gene expression signature for high-grade serous ovarian cancerMillstein, J., Budden, T., Goode, E.L., Anglesio, M.S., Talhouk, A., Intermaggio, M.P., Leong, H.S., Chen, S., Elatre, W., Gilks, B., Nazeran, T., Volchek, M., Bentley, R.C., Wang, C., Chiu, D.S., Kommoss, S., Leung, S.C.Y., Senz, J., Lum, A., Chow, V., Sudderuddin, H., Mackenzie, R., George, J., Fereday, S., Hendley, J., Traficante, N., Steed, H., Koziak, J.M., Köbel, M. ... AOCS Group (2020). Prognostic gene expression signature for high-grade serous ovarian cancer. Annals of Oncology, 31 (9), 1240-1250. doi: 10.1016/j.annonc.2020.05.019 |
|
2020 Journal Article Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumoursLim, Lisi Elizabeth, Chan, David L., Thomas, David, Du, Yang, Tincknell, Gary, Kuchel, Anna, Davis, Alexander, Bailey, Dale L., Pavlakis, Nick, Cehic, Gabrielle, Macdonald, William, Wyld, David and Segelov, Eva (2020). Australian experience of peptide receptor radionuclide therapy in lung neuroendocrine tumours. OncoTarget, 11 (27), 2636-2646. doi: 10.18632/oncotarget.27659 |
|
2020 Journal Article The (co)production of difference in the care of patients with cancer from migrant backgroundsBroom, Alex, Parker, Rhiannon, Raymond, Stephanie, Kirby, Emma, Lewis, Sophie, Kokanović, Renata, Adams, Jonathan, de Souza, Paul, Woodland, Lisa, Wyld, David, Lwin, Zarnie and Koh, Eng-Siew (2020). The (co)production of difference in the care of patients with cancer from migrant backgrounds. Qualitative Health Research, 30 (11), 1049732320930699-1631. doi: 10.1177/1049732320930699 |
|
2020 Journal Article Supporting patients and carers affected by pancreatic cancer: a feasibility study of a counselling interventionBeesley, Vanessa L., Turner, Jane M., Chan, Raymond J., Yates, Patsy, Gordon, Louisa G., Burge, Matthew, Eastgate, Melissa A., Staneva, Aleksandra A., Northfield, Sarah, Beebe, Hanna, Wyld, David K. and Neale, Rachel E. (2020). Supporting patients and carers affected by pancreatic cancer: a feasibility study of a counselling intervention. European Journal of Oncology Nursing, 46 101729, 101729. doi: 10.1016/j.ejon.2020.101729 |
|
2020 Conference Publication P3BEP (ANZUP 1302): an international randomized phase III trial of accelerated versus standard BEP chemotherapy for adult and pediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs)Subramaniam, Shalini, Toner, Guy C., Stockler, Martin R., Martin, Andrew James, Pashankar, Farzana D., Frazier, A. Lindsay, Mazhar, Danish, Ford, Kate, Walpole, Euan Thomas, Stevanovic, Amanda Gwendolyn, Wyld, David, Troon, Simon, Hanning, Fritha J., Birtle, Alison Jane, Wheater, Matthew James, Huddart, Robert A., White, Jeff D., Spunt, Sheri L. and Grimison, Peter S. (2020). P3BEP (ANZUP 1302): an international randomized phase III trial of accelerated versus standard BEP chemotherapy for adult and pediatric male and female patients with intermediate and poor-risk metastatic germ cell tumors (GCTs). Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San Francisco, CA USA, 13-15 February 2020. Alexandria, VA: American Society of Clinical Oncology. |
|
2020 Journal Article The economic impact on Australian patients with neuroendocrine tumoursGordon, Louisa G., Elliott, Thomas M., Wakelin, Kate, Leyden, Simone, Leyden, John, Michael, Michael, Pavlakis, Nick, Mumford, Jan, Segelov, Eva and Wyld, David K. (2020). The economic impact on Australian patients with neuroendocrine tumours. The Patient - Patient-Centered Outcomes Research, 13 (3), 363-373. doi: 10.1007/s40271-020-00412-z |
|
2020 Journal Article The INTERNET STUDY: a phase II study of everolimus in patients with fluorodeoxyglucose (18F) positron-emission tomography positive intermediate grade pancreatic neuroendocrine tumorsLung, Mei Sim, Hicks, Rodney J, Pavlakis, Nick, Link, Emma, Jefford, Michael, Thomson, Benjamin, Wyld, David K, Liauw, Winston, Akhurst, Timothy, Kuru, Narmatha and Michael, Michael (2020). The INTERNET STUDY: a phase II study of everolimus in patients with fluorodeoxyglucose (18F) positron-emission tomography positive intermediate grade pancreatic neuroendocrine tumors. Asia-Pacific Journal of Clinical Oncology, 16 (3) ajco.13307, 150-157. doi: 10.1111/ajco.13307 |
|
2020 Conference Publication Insights into the practice patterns, challenges and the role of a shared care model in the management of neuroendocrine (NET) patients in the communityRadhika, Y., Chan, D., Thawer, A., Lo, D., Singh, S. and Wyld, D. (2020). Insights into the practice patterns, challenges and the role of a shared care model in the management of neuroendocrine (NET) patients in the community. 17th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease, Electr Network, 11-13 March 2020. Basel, Switzerland: S. Karger. |
|
2020 Journal Article Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinomaKryza, Thomas, Khan, Tashbib, Puttick, Simon, Li, Chao, Sokolowski, Kamil A., Tse, Brian W.C., Cuda, Tahleesa, Lyons, Nicholas, Gough, Madeline, Yin, Julia, Parkin, Ashleigh, Deryugina, Elena I., Quigley, James P., Law, Ruby H.P., Whisstock, James C., Riddell, Andrew D., Barbour, Andrew P., Wyld, David K., Thomas, Paul A., Rose, Stephen, Snell, Cameron E., Pajic, Marina, He, Yaowu and Hooper, John D. (2020). Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma. Theranostics, 10 (9), 4116-4133. doi: 10.7150/thno.43589 |
|
2019 Journal Article Defining the supportive care needs and psychological morbidity of patients with functioning versus nonfunctioning neuroendocrine tumors: Protocol for a phase 1 trial of a nurse-led online and phone-based interventionGuccione, Lisa, Gough, Karla, Drosdowsky, Allison, Fisher, Krista, Price, Timothy, Pavlakis, Nick, Khasraw, Mustafa, Wyld, David, Ransom, David, Kong, Grace, Rogers, Megan, Leyden, Simone, Leyden, John, Michael, Michael and Schofield, Penelope (2019). Defining the supportive care needs and psychological morbidity of patients with functioning versus nonfunctioning neuroendocrine tumors: Protocol for a phase 1 trial of a nurse-led online and phone-based intervention. JMIR Research Protocols, 8 (12) e14361, e14361. doi: 10.2196/14361 |
|
2019 Journal Article Epidemiological trends of neuroendocrine tumours over three decades in Queensland, AustraliaWyld, David, Wan, Mark H., Moore, Julie, Dunn, Nathan and Youl, Philippa (2019). Epidemiological trends of neuroendocrine tumours over three decades in Queensland, Australia. Cancer Epidemiology, 63 101598, 101598. doi: 10.1016/j.canep.2019.101598 |
|
2019 Journal Article Factors in randomized controlled trials reported to impact the implementation of patient-reported outcome measures into routine care: protocol for a systematic reviewRoberts, Natasha Anne, Alexander, Kimberly, Wyld, David and Janda, Monika (2019). Factors in randomized controlled trials reported to impact the implementation of patient-reported outcome measures into routine care: protocol for a systematic review. JMIR Research Protocols, 8 (11) e14579, e14579. doi: 10.2196/14579 |
|
2019 Journal Article How do cancer care services in Australia take care of their patients when they require emergency care? We need more evidenceButton, Elise, Northfield, Sarah, Smith, Michael, Wyld, David, Nasato, Gillian and Yates, Patsy (2019). How do cancer care services in Australia take care of their patients when they require emergency care? We need more evidence. Australian Health Review, 44 (3), 497-498. doi: 10.1071/AH19118 |
